Press Releases - 2021-09-15

Date	Title	Company
15-Sep-2021	Rapid Dose Therapeutics and McMaster University Provide COVID-19 Vaccine Research Update Including Significant Achievement of Milestones	Businesswire
15-Sep-2021	LabVantage Solutions Introduces LabVantage Enterprise SaaS	Businesswire
15-Sep-2021	CBD Oil Extract Market 2021 Business Revenue, Size, Share, Future Growth, Trends Plans, Top Key Players, Business Opportunities, Industry Share, Global Size Analysis by Forecast to 2028	The Wire Times
15-Sep-2021	GammaDelta Therapeutics Initiates First-in-Human Phase 1 Trial of GDX012 for the Treatment of Acute Myeloid Leukaemia	Businesswire
15-Sep-2021	Spinal Elements® Announces Full Commercial Launch of Luna® XD and Orbit™ Systems	Businesswire
15-Sep-2021	Medical Clothing Market Size, Global Analysis by Growth, Share, Demand, Trends, Business Opportunity: 3M, Ansell Ltd., BBN Medical Equipment, Cardinal Health	The Wire Times
15-Sep-2021	4D pharma Presents Two Clinical Posters for Live Biotherapeutic MRx0518 at the European Society for Medical Oncology (ESMO) Congress 2021	Businesswire
15-Sep-2021	Flywheel and Radiologics Join Forces to Create a Truly Unique Global Network for Biomedical Research and Collaboration	Businesswire
15-Sep-2021	Allay Therapeutics Completes Oversubscribed $60M Financing to Advance Ultra-Sustained Pain Platform	Businesswire
15-Sep-2021	Exicure to Participate in Upcoming Scientific Conferences	Businesswire
15-Sep-2021	Vigil Neuroscience Announces First Subject Enrolled in a Natural History Study of Patients with Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)	Businesswire
15-Sep-2021	Flywheel Raises $22M in Series C Funding	Businesswire
15-Sep-2021	U.S. FDA Grants BRUKINSA® (Zanubrutinib) Accelerated Approval in Relapsed or Refractory Marginal Zone Lymphoma	Businesswire
15-Sep-2021	Within3 Reimagines Life Science Communications to Address Insights Gap with Industry-First, Holistic Platform	Businesswire
15-Sep-2021	Seres Therapeutics Achieves Enrollment of 300 Subjects with Phase 3 ECOSPOR IV Open-Label Extension Study of SER-109, a Potentially First-in-Class Investigational Microbiome Therapeutic for Recurrent C. difficile Infection	Businesswire
15-Sep-2021	SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza	Businesswire
15-Sep-2021	Glaukos Announces Settlement of Patent Litigation with Ivantis, Inc.	Businesswire
15-Sep-2021	Europe CBD Oil Market 2021: Global Size, Share, Trends, Growth, Revenue, Application \| KANIBI, GREEN GORILLA, Spruce Natural Labs LLC	The Wire Times
15-Sep-2021	Howard Kennedy advises Polski Bank Komorek Macierzystych on its purchase of a majority stake in Smart Cells, the UK's first private cord blood stem cell storage company	Smart Cells
15-Sep-2021	Legal Marijuana Market-Global Industry Share, Size, Segmentation, Business Opportunity \| VIVO Cannabis, Dr. Hemp Me., QC Infusion	The Wire Times